StockData
Glucose Health, Inc. logo

Glucose Health, Inc. (GLUC) stock

GLUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2017, quarter ended Sep 30, 2017Last filing: 10-Q on Nov 14, 2017
$0.44+0.10 (+28.76%)

Close on Oct 19, 2026Market cap $1.82MP/E –Yield –

Glucose Health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Glucose Health's price to sales ratio was 22.5× on Oct 19, 2026, against 11.0× a year earlier. Over the last 5 years it ranged from 2.6× to 112.7×, with a median of 18.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 202622.5×+11.6
2025Dec 31, 202510.9×+4.8
2024Dec 31, 20246.1×−8.2
2023Dec 29, 202314.3×−15.9
2022Dec 30, 202230.2×−54.3
2021Dec 31, 202184.5×−217.8
2020Dec 31, 2020302.3×+295.9
2019Dec 31, 20196.4×+1.3
2018Dec 31, 20185.1×+0.0
2017Dec 29, 20175.1×+4.7
2016Dec 30, 20160.4×−41.4
2015Dec 31, 201541.8×+19.7
2014Dec 31, 201422.1×–

More Glucose Health figures

See a number that looks wrong?